Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Jun;293(3):209-15.
doi: 10.1007/BF00507343.

3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo

3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo

W Kehr. Naunyn Schmiedebergs Arch Pharmacol. 1976 Jun.

Abstract

3-Methoxtyramine and dopamine accumulated in vivo in rat brain after monoamine oxidase inhibition with pargyline HCl. A dose of 100 mg/kg i.p. appeared to inhibit monoamine oxidase completely and led to a linear accumulation of 3-methoxytyramine for the first 90 min. Axotomy of the ascending dopaminergic fiber tract by means of a complete transverse cerebral hemisection almost completely blocked 3-methoxytyramine formation provided that catecholamine synthesis was inhibited with H 44/68 (Methylester of alpha-methyl-p-tyrosine). The dopamine receptor agonist apomorphine, 0.5 mg/kg i.p., decreased, while the dopamine receptor antagonist haloperidol, 2 mg/kg i.p., accelerated 3-methoxytyramine formation. gamma-Butyrolactone, 750 mg/kg i.p., not only decreased 3-methoxytyramine formation per se but also effectively antagonized the haloperidol-induced increase in 3-methoxytyramine accumulation. 3-Methoxytyramine formation after inhibition of monoamine oxidase appears to be a reliable indicator of impulse-induced dopamine release and metabolism.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Physiol. 1968 Feb;194(2):565-72 - PubMed
    1. J Pharmacol Exp Ther. 1966 Dec;154(3):493-8 - PubMed
    1. J Physiol. 1969 Oct;204(3):687-715 - PubMed
    1. Br J Pharmacol. 1973 Aug;48(4):699-714 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1974;284(4):365-72 - PubMed